{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    20,
    21,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "AZD7442",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Single 600 mg dose of AZD7442 administered as 2 separate IM injections of 300 mg each (AZD8895 and AZD1061) on Day 1."
      },
      {
        "id": "arm_2",
        "name": "Placebo",
        "type": {
          "code": "Placebo Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Placebo Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Single IM dose of placebo administered on Day 1."
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_1"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_2"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_3"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_1",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_4"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_5"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_6"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_7"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_2",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_8"
        ],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [
      {
        "id": "cohort_1",
        "name": "Cohort 1",
        "instanceType": "StudyCohort",
        "characteristic": "Participants undergoing intensive testing for virological and immunological status (includes sentinel group)."
      },
      {
        "id": "cohort_2",
        "name": "Cohort 2",
        "instanceType": "StudyCohort",
        "characteristic": "Participants followed primarily for clinical outcomes."
      }
    ],
    "studyElements": [
      {
        "id": "elem_1",
        "name": "AZD7442 - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for AZD7442 during Screening"
      },
      {
        "id": "elem_2",
        "name": "AZD7442 - Treatment and Intensive Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for AZD7442 during Treatment and Intensive Follow-up"
      },
      {
        "id": "elem_3",
        "name": "AZD7442 - Limited Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for AZD7442 during Limited Follow-up"
      },
      {
        "id": "elem_4",
        "name": "AZD7442 - Early Discontinuation Visit",
        "instanceType": "StudyElement",
        "description": "Treatment period for AZD7442 during Early Discontinuation Visit"
      },
      {
        "id": "elem_5",
        "name": "Placebo - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo during Screening"
      },
      {
        "id": "elem_6",
        "name": "Placebo - Treatment and Intensive Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo during Treatment and Intensive Follow-up"
      },
      {
        "id": "elem_7",
        "name": "Placebo - Limited Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo during Limited Follow-up"
      },
      {
        "id": "elem_8",
        "name": "Placebo - Early Discontinuation Visit",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo during Early Discontinuation Visit"
      }
    ],
    "summary": {
      "armCount": 2,
      "cellCount": 8,
      "cohortCount": 2,
      "elementCount": 8
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Double Blind",
        "codeSystem": "USDM",
        "decode": "Double Blind"
      },
      "maskedRoles": [
        "Subject",
        "Investigator",
        "Caregiver",
        "Data Analyst"
      ],
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "allocationRatio": {
        "ratio": "1:1"
      },
      "stratificationFactors": [
        "Time from symptom onset (<= 5 days vs > 5 days)",
        "High-risk versus low-risk of progression to severe COVID-19"
      ],
      "controlType": {
        "code": "Placebo Control",
        "codeSystem": "USDM",
        "decode": "Placebo Control"
      },
      "armIds": [
        "arm_1",
        "arm_2"
      ],
      "cohortIds": [
        "cohort_1",
        "cohort_2"
      ],
      "therapeuticAreas": [
        "Infectious Disease"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment"
      ],
      "blinding": {
        "schema": "Double Blind",
        "maskedRoles": [
          "Subject",
          "Investigator",
          "Caregiver",
          "Data Analyst"
        ]
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": "1:1",
        "stratificationFactors": [
          "Time from symptom onset (<= 5 days vs > 5 days)",
          "High-risk versus low-risk of progression to severe COVID-19"
        ]
      },
      "controlType": "Placebo",
      "therapeuticAreas": [
        "Infectious Disease"
      ]
    },
    "arms": [
      {
        "name": "AZD7442",
        "type": "Experimental Arm",
        "description": "Single 600 mg dose of AZD7442 administered as 2 separate IM injections of 300 mg each (AZD8895 and AZD1061) on Day 1.",
        "isTitration": false,
        "doseEpochs": null
      },
      {
        "name": "Placebo",
        "type": "Placebo Comparator",
        "description": "Single IM dose of placebo administered on Day 1.",
        "isTitration": false,
        "doseEpochs": null
      }
    ],
    "cohorts": [
      {
        "name": "Cohort 1",
        "characteristic": "Participants undergoing intensive testing for virological and immunological status (includes sentinel group)."
      },
      {
        "name": "Cohort 2",
        "characteristic": "Participants followed primarily for clinical outcomes."
      }
    ],
    "epochs": [
      {
        "name": "Screening",
        "description": "Up to 3 days prior to study entry to document SARS-CoV-2 infection and eligibility."
      },
      {
        "name": "Treatment and Intensive Follow-up",
        "description": "Day 1 (dosing) through Day 28."
      },
      {
        "name": "Limited Follow-up",
        "description": "Day 29 through Day 457."
      },
      {
        "name": "Early Discontinuation Visit",
        "description": "Visit for participants who withdraw from the study prior to Day 457."
      }
    ]
  }
}